Bernard CouliePresident and CEO at Pliant Therapeutics
Bernard Coulie, M.D., Ph.D., is serving as President and Chief Executive Officer of Pliant Therapeutics, a biopharma company focused on delivering novel treatments for patients with fibrotic diseases. Under his leadership, Pliant raised over $200 Million in capital, including a partnership agreement with Novartis covering Pliant’s program in NASH-liver fibrosis. He joined Pliant in 2016 from ActoGeniX, where he was CEO, Chief Medical Officer and Co-Founder. Prior to ActoGeniX, he held various positions in drug discovery and clinical development at Johnson & Johnson Pharmaceutical Research and Development Europe. At Johnson & Johnson, he served as Therapeutic Area Leader Internal Medicine, managing a portfolio of preclinical and clinical products in GI, metabolic diseases and inflammation/immunology. Earlier in his career, Dr. Coulie was a Staff Physician in the Department of Gastroenterology and Hepatology at Mayo Clinic (Rochester, MN), Assistant Professor in Medicine at Mayo Medical School and a Mayo Foundation scholar.